The Global Antibiotic Research & Development Partnership (GARDP) is a non-profit product development partnership. It is a research and development initiative addressing global public health needs by developing, delivering and assuring sustainable access of new or improved antibiotic treatments. UK Department of Health and Social Care (DHSC) funding through the Global AMR Innovation Fund (GAMRIF) will support GARDP’s programme on sexually transmitted infections (STI), specifically focusing on the development of a new antibiotic for drug-resistant gonorrhoea. The aim of this project is to fund and support the development of new treatments that address the threat of drug-resistant gonorrhoea in low- and middle- income countries (LMICs). Objectives of the funded activity are to: - develop a new affordable treatment for gonorrhoea, that works on multi-drug resistant cases (trials completed and registration started by 2022) - support the integration of the new treatments into the current Sexually Transmitted Infection management framework by investigating possible antibiotic combinations by 2023; and - support the development of a stewardship and access strategy for LMICs for the new antibiotic treatment. Projects funded through GAMRIF will primarily benefit people in LMICs, where the burden of drug-resistant infection is greater.
more_horizOrganisation Name | Organisation Type | Organisation Role |
---|---|---|
UK - Department of Health and Social Care (DHSC) | Government | Accountable |
UK - Department of Health and Social Care (DHSC) | Government | Funding |
Global Antibiotic Research and Development Partnership | Public Private Partnership | Implementing |
Transaction Value | Provider |
Type | Date |
---|---|---|---|
768,068 GBP (Valued at Dec 15, 2021) | circle UK - Department of Health and Social Care (DHSC) circle Global Antibiotic Research and Development Partnership | Disbursement | date_rangeDec 15, 2021 |
2,051,474 GBP (Valued at Dec 15, 2020) | circle UK - Department of Health and Social Care (DHSC) circle Global Antibiotic Research and Development Partnership | Disbursement | date_rangeDec 15, 2020 |
677,240 GBP (Valued at Dec 06, 2020) | circle UK - Department of Health and Social Care (DHSC) circle Global Antibiotic Research and Development Partnership | Disbursement | date_rangeDec 06, 2020 |
1,503,218 GBP (Valued at Nov 22, 2019) | circle UK - Department of Health and Social Care (DHSC) circle Global Antibiotic Research and Development Partnership | Disbursement | date_rangeNov 22, 2019 |
5,000,000 GBP (Valued at Jul 01, 2019) | circle UK - Department of Health and Social Care (DHSC) circle Receiver N/A | Commitment | date_rangeJul 01, 2019 |
1,503,218 GBP (Valued at Jul 01, 2019) | date_range Jul 01, 2019 - Mar 31, 2020 |
677,240 GBP (Valued at Apr 01, 2020) | date_range Apr 01, 2020 - Sep 30, 2020 |
2,051,474 GBP (Valued at Oct 01, 2020) | date_range Oct 01, 2020 - Mar 31, 2021 |
374,880 GBP (Valued at Apr 01, 2021) | date_range Apr 01, 2021 - Sep 30, 2021 |
393,187 GBP (Valued at Oct 01, 2021) | date_range Oct 01, 2021 - Mar 31, 2022 |